Try our beta test site
427 studies found for:    Open Studies | "Schizophrenia"
Show Display Options
Rank Status Study
21 Recruiting Carnosine and Cognitive Training in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: L-Carnosine;   Drug: Placebo;   Behavioral: Cognitive Training
22 Recruiting Music Therapy Towards Schizophrenia, Negative Symptoms
Condition: Schizophrenia
Interventions: Other: Music therapy;   Other: Music Listening
23 Recruiting Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia
Condition: Schizophrenia
24 Recruiting Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Olanzapine;   Drug: Paliperidone
25 Not yet recruiting Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Placebo;   Drug: Cannabidiol
26 Recruiting Measuring Time Windows in Patients With Schizophrenia and Healthy Controls
Condition: Schizophrenia
Intervention: Procedure: EEG
27 Recruiting Cognitive Remediation and Sheltered Employment in Schizophrenia
Condition: Chronic Schizophrenia
Interventions: Behavioral: RECOS (COgnitive REmediation for Schizophrenia);   Behavioral: TAU (Treatment As Usual)
28 Recruiting Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia
Condition: Schizophrenia
29 Recruiting A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
Condition: Schizophrenia
Interventions: Drug: ALK3831;   Drug: Olanzapine;   Drug: Placebo
30 Recruiting The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism
Condition: Schizophrenia
Interventions: Biological: omega-3 fatty acid;   Biological: placebo;   Device: positron emission tomography (PET)
31 Not yet recruiting TMS for Symptom Reduction in Schizophrenia
Condition: Schizophrenia and Related Disorders
Interventions: Device: Active rTMS stimulation;   Device: Sham rTMS stimulation
32 Recruiting Neuroendocrine and Metabolite Substrates in Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Risperidone
33 Recruiting Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia
Condition: Schizophrenia
Interventions: Behavioral: Brain Fitness Program (BFP);   Behavioral: Cognitive Package (Cogpack);   Behavioral: Commercial Computer Games (Sporcle)
34 Recruiting Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Condition: Schizophrenia
Interventions: Other: Caregiver psycho-education and skills training;   Other: Caregiver support available at the study site;   Drug: Paliperidone palmitate;   Drug: Chlorpromazine;   Drug: Droperidol;   Drug: Fluphenazine;   Drug: Haloperidol;   Drug: Loxapine;   Drug: Perphenazine;   Drug: Pimozide;   Drug: Prochlorperazine;   Drug: Thiothixene;   Drug: Thioridazine;   Drug: Trifluoperazine;   Drug: Aripiprazole;   Drug: Asenapine;   Drug: Clozapine;   Drug: Iloperidone;   Drug: Olanzapine;   Drug: Paliperidone;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Ziprasidone
35 Recruiting Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
Condition: Schizophrenia
Intervention: Drug: paliperidone
36 Recruiting Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Memantine;   Drug: Placebo
37 Recruiting Famotidine in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Famotidine;   Drug: Placebo
38 Not yet recruiting "Manual Dexterity and Oculomotor Control in Schizophrenia"
Condition: Schizophrenia
Interventions: Device: Manual dexterity;   Device: Oculomotor movements;   Device: TMS coupled to EMG recording;   Other: Psychopathological evaluations;   Other: Neuropsychological evaluations
39 Recruiting A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
Condition: Schizophrenia
Interventions: Drug: ALKS 3831;   Drug: Olanzapine
40 Not yet recruiting An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
Condition: Schizophrenia, Acute Episode
Interventions: Drug: MK-8189;   Drug: Risperidine;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.